Thomas, > drugref.org was published 1/26/2003. It needs additional publication > and time before acceptance and receiving participation from people with > a 'medical, pharmaceutical, or biochemical degree'. True.
> It needs expanded > scope as well since side effects are major concerns with drugs and > drug databases. I am sure the drugref people would like to hear your suggestions. > Since I have a collection of Engineering, Computer Science and Law > degrees, plus personal experience, I am not included within the > stated membership. Restricted globalization might be a better title. Ah, well, this time you're reading too much into the letter :-) I am quite sure Horst/Ian would openly welcome your participation. > As for open-source, this is one area where source code control is a > necessity. SQA (Software Quality Assurance) has stringent > requirements often not met with open peer review. One idea was to have med/pharm schools make their students adopt a drug as an assignment and take care of that drug for a semester the data being reviewed by an (assistant) professor or some such (not my idea but rather, I think, Tim Churches' or Tim Cooks or ...). Given enough schools doing this the quality would be pretty high. Still, commercial firms may want to sell the service of independantly reviewing the data and reselling that review/"approval" which IMHO is fully legal with drugref's current license. Karsten -- GPG key ID E4071346 @ wwwkeys.pgp.net E167 67FD A291 2BEA 73BD 4537 78B9 A9F9 E407 1346 - If you have any questions about using this list, please send a message to d.lloyd at openehr.org
